1. An Overview of the Orphan Medicines Market in Turkey
Güvenç Koçkaya, MD, MsC, Albert I. Wertheimer, MBA, PhD, Pelin Kilic, MsC, Pelin Tanyeri, MD, İ. Mert Vural, MD, Akif Akbulat, MD, Guven Artiran, MD, Saim Kerman, MD 
Value in Health Regional Issues 
Volume 4, Pages (September 2014)
DOI: /j.vhri
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Overview of licensed product market access in Turkey [17]. MEEC, Medical and Economic Evaluation Commission; SGK, Sosyal Güvenlik Kurumu; TITCK, Türkiye İlaç ve Tıbbi Cihaz Kurumu.
Value in Health Regional Issues 2014 4, 47-52DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2 Changes in units and expenditures from 2008 to 2010.
Value in Health Regional Issues 2014 4, 47-52DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions